Abstract |
We investigated the association between a polymorphism of a key innate immunity receptor, Toll-like receptor 1 (TLR1) N248S, and susceptibility to leprosy and its clinical presentation. TLR1 N248S has been shown elsewhere to diminish TLR1 signaling and subsequent leprosy disease. The homozygous genotype SS was more frequent (P=.012) and the heterozygous SN genotype was less frequent (P=.015) in patients with leprosy than in control subjects. Additional observed differences in allelic frequency in patients who experienced reversal reactions and/or erythema nodosum leprosum reactions indicates that altered TLR1 function, or at least a TLR1 N248S-linked trait, may affect the progression from infection to disease as well as the disease course and the risk of debilitating reactional episodes in this population.
|
Authors | Ron P Schuring, Lutz Hamann, William R Faber, David Pahan, Jan Hendrik Richardus, Ralf R Schumann, Linda Oskam |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 199
Issue 12
Pg. 1816-9
(Jun 15 2009)
ISSN: 0022-1899 [Print] United States |
PMID | 19456232
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Alleles
- Case-Control Studies
- Genetic Predisposition to Disease
- Genotype
- Humans
- Leprosy
(genetics, pathology)
- Odds Ratio
- Polymorphism, Single Nucleotide
- Toll-Like Receptor 1
(genetics, metabolism)
|